-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Reiterates Neutral on Collegium Pharmaceutical, Raises Price Target to $37

Benzinga·05/09/2025 14:33:31
Listen to the news
Piper Sandler analyst David Amsellem reiterates Collegium Pharmaceutical (NASDAQ:COLL) with a Neutral and raises the price target from $36 to $37.